Viewing StudyNCT06299709



Ignite Creation Date: 2024-05-06 @ 8:13 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06299709
Status: COMPLETED
Last Update Posted: 2024-06-24
First Post: 2024-02-29

Brief Title: A Study To Evaluate the Relative Bioavailability Food Effect and Dose Proportionality of a Granule Formulation of VanzacaftorTezacaftorDeutivacaftorVNZTEZD-IVA
Sponsor: Vertex Pharmaceuticals Incorporated
Organization: Vertex Pharmaceuticals Incorporated

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-03-13
Start Date Type: ACTUAL
Primary Completion Date: 2024-05-23
Primary Completion Date Type: ACTUAL
Completion Date: 2024-05-23
Completion Date Type: ACTUAL
First Submit Date: 2024-02-29
First Submit QC Date: February 29 2024
Study First Post Date: 2024-03-08
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-21
Last Update Post Date: 2024-06-24
Last Update Post Date Type: ACTUAL